Capture
Multi-photo fusion into a landmark-referenced 3D model.
Orthonose
A cleared device in clinic. A piloted growth line on the same platform.
Orthonose Surgery is already treating patients. Interceptive extends the same landmark-referenced 3D stack into supervised adolescent care.
Today
Already in the operating room
Orthonose® Surgery is CE-marked Class IIa in Europe and FDA-cleared in the US. Made in France.
250+
Patients treated
Clinical series built alongside eight years of surgeon-led R&D.
3
Surgeons live
Practising Paris rhinoplasty surgeons using the platform in clinic.
CE + FDA
Regulated
Class IIa in Europe; FDA-cleared in the US. Made in France.
The problem
Rhinoplasty still flies blind
Planning often stays in 2D, without anatomical landmarks — so the result can miss the shape the patient approved.
How it works
Capture, plan, treat
A sub-millimeter landmark map of the face drives both surgical guides and growth forecasting.
Plan
Proprietary algorithms forecast development and lock an agreed plan.
Treat
Patient-matched 3D-printed guides carry that plan into theatre.
Technology & moat
The moat is the landmarks
Landmark referencing to sub-millimeter precision enables growth forecasting that photogrammetry alone cannot deliver. The landmarks and the growth algorithm are the moat; the labelled dataset is the flywheel that compounds them.
Surgery — selling
CE-marked Class IIa and FDA-cleared surgical guides, already used in clinic. Commercial revenue on a per-case device model.
Interceptive — piloted
Supervised night-worn orthoses under clinician care. Initial series: 4/4 treated vs 8/8 untreated, with tip projection preserved in every treated patient.
Preliminary evidence: a small, non-randomized proof-of-concept series. Larger independent studies and follow-up through nasal maturity are needed.
Team
Surgeon-founded, operator-led
Clinical depth in the founding team, with commercial leadership to scale both lines.
Kristoffer Laurson
Chief Executive Officer
Investor contact
Request the public narrative pack
For the data room and a founder conversation, write to Dr. Marc-David Benjoar. Confidential raise materials are shared under NDA — not published here.